Here are what the editors at HealthDay consider to be the most important developments in Dermatology for March 2017. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Vertical Integration Insurance Products of Higher Quality
FRIDAY, March 31, 2017 (HealthDay News) -- Insurance products offered by hospitals and health systems, known as vertical integration, are generally of higher quality than other contracts, according to a study published in the March issue of Health Affairs.
Abstract
Full Text (subscription or payment may be required)
90 Percent of U.S. Physicians Satisfied With Career Choice
FRIDAY, March 31, 2017 (HealthDay News) -- Nine out of 10 American doctors are happy with their choice of profession, even though they have some challenges, according to an American Medical Association (AMA) survey of 1,200 doctors, residents, and medical students, conducted in February.
Doctors Should Consider QoL in Tx of Facial Port-Wine Stain
FRIDAY, March 31, 2017 (HealthDay News) -- Having a facial port-wine stain (PWS) has a significant negative impact on patient quality of life (QoL), according to a study published in the April issue of the Journal of the American Academy of Dermatology.
Abstract
Full Text (subscription or payment may be required)
FDA Approves Dupixent to Treat Eczema
WEDNESDAY, March 29, 2017 (HealthDay News) -- Dupixent (dupilumab) has been approved by the U.S. Food and Drug Administration to treat moderate-to-severe eczema that isn't well controlled by topical medication.
TV Ads for ACA Enrollment Linked to Decline in Uninsured Rates
TUESDAY, March 28, 2017 (HealthDay News) -- The volume of insurance advertisements during the first Affordable Care Act enrollment period correlated with change in uninsurance rates, with a higher volume of television advertisements linked to declines in uninsurance, according to a study published online March 15 in Health Affairs.
Abstract
Full Text (subscription or payment may be required)
ACP Issues Challenge to Cut Task Burden and Put Patients First
TUESDAY, March 28, 2017 (HealthDay News) -- In a position paper published online March 28 in the Annals of Internal Medicine, recommendations are presented to address the impact of administrative tasks and reduce the administrative burden on clinicians.
Abstract/Full Text
Editorial (subscription or payment may be required)
Psoriasis May Up Risk of Melanoma, Hematologic Cancer
TUESDAY, March 28, 2017 (HealthDay News) -- Patients with psoriasis may have a higher risk of melanoma and hematologic cancers than the general population, according to a study published in the April issue of the Journal of the American Academy of Dermatology.
Abstract
Full Text (subscription or payment may be required)
Paid Malpractice Claims Cut in Half From 1992 to 2014 in U.S.
MONDAY, March 27, 2017 (HealthDay News) -- From 1992 to 2014 there was a decrease in the rate of malpractice claims paid on behalf of physicians in the United States, but mean compensation amounts increased, according to a study published online March 27 in JAMA Internal Medicine.
Abstract/Full Text (subscription or payment may be required)
Suicide Risk Not Up With New Rx of 5α-Reductase Inhibitor for BPH
MONDAY, March 27, 2017 (HealthDay News) -- For older men, initiation of a new prescription of a 5α-reductase inhibitor for the treatment of benign prostatic hyperplasia is not associated with increased risk of suicide, according to a study published online March 20 in JAMA Internal Medicine.
Abstract/Full Text
Editorial (subscription or payment may be required)
Advanced Age Need Not Deter Surgery for Cutaneous Tumors
MONDAY, March 27, 2017 (HealthDay News) -- Surgery for cutaneous tumors under local anesthesia is as well tolerated in elderly patients 90 years and older as it is in patients aged 75 to 80 years old, according to a study published online March 21 in the International Journal of Dermatology.
Abstract
Full Text (subscription or payment may be required)
Optical Clearing Agent Ups No. of Laser Passes in Tattoo Removal
FRIDAY, March 24, 2017 (HealthDay News) -- Use of a transparent perfluorodecalin (PFD)-infused patch during laser-assisted tattoo removal allows significantly more passes in one sitting than possible with the laser alone, according to a study published online March 20 in Lasers in Surgery and Medicine.
Abstract
Full Text (subscription or payment may be required)
FDA Approves Bavencio for Merkel Cell Carcinoma
THURSDAY, March 23, 2017 (HealthDay News) -- Bavencio (avelumab) has been approved by the U.S. Food and Drug Administration to treat Merkel cell carcinoma (MCC), the agency said Thursday in a news release.
30-Day Mortality Down During Joint Commission Survey Weeks
THURSDAY, March 23, 2017 (HealthDay News) -- Patients admitted to the hospital during The Joint Commission on-site inspections (surveys) have reduced mortality compared to that seen during non-survey weeks, according to research published online March 20 in JAMA Internal Medicine.
C1 Inhibitor Use Reduces Attacks in Hereditary Angioedema
THURSDAY, March 23, 2017 (HealthDay News) -- Prophylactic use of the subcutaneous C1 inhibitor CSL830 is associated with a reduction in the frequency of acute attacks in patients with hereditary angioedema, according to a study published in the March 23 issue of the New England Journal of Medicine.
Abstract/Full Text (subscription or payment may be required)
Black, Asian Medical Students Less Likely to Be AΩA Members
TUESDAY, March 21, 2017 (HealthDay News) -- Black and Asian medical students are less likely to be members of the Alpha Omega Alpha (AΩA) honor society than white students, according to a study published online March 6 in JAMA Internal Medicine.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Phthalate, Paraben Levels Up in Children With Atopic Dermatitis
TUESDAY, March 21, 2017 (HealthDay News) -- Children aged 4 to 9 years with atopic dermatitis and with frequent use of emollients have increased urinary levels of low-molecular weight (LMW) phthalate metabolites and parabens, according to a study published online March 9 in Allergy.
Abstract
Full Text (subscription or payment may be required)
Hyaluronic Acid, Autologous Fat Augment Nasolabial Folds
MONDAY, March 20, 2017 (HealthDay News) -- Hyaluronic acid (HA) and autologous fat are both beneficial for augmentation of nasolabial folds (NLFs), according to a study published online March 14 in the Journal of Cosmetic Dermatology.
Abstract
Full Text (subscription or payment may be required)
Los Angeles eConsult Program Can Reduce Wait Times
FRIDAY, March 17, 2017 (HealthDay News) -- Implementation of an electronic system for provision of specialty care was rapidly adopted in Los Angeles, and it can reduce wait times to see specialists, according to a study published in the March issue of Health Affairs.
Abstract
Full Text (subscription or payment may be required)
Hyperbaric Oxygen Tx Beneficial for Systemic Sclerosis Ulcers
THURSDAY, March 16, 2017 (HealthDay News) -- Adjunctive hyperbaric oxygen therapy (HBOT) may be beneficial for treatment of systemic sclerosis (SSc) ulcers, according to a report published online Feb. 23 in the International Journal of Dermatology.
Abstract
Full Text (subscription or payment may be required)
Women Underrepresented Among Grand Rounds Speakers
WEDNESDAY, March 15, 2017 (HealthDay News) -- Women seem to be underrepresented among academic grand rounds (GR) speakers, according to a research letter published online March 6 in JAMA Internal Medicine.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Antibiotics Ineffective for Mildly Infected Eczema in Children
TUESDAY, March 14, 2017 (HealthDay News) -- Despite widespread use, antibiotics are not an effective treatment for mild clinically infected eczema in children, according to a study published in the March/April issue of the Annals of Family Medicine.
Support for Health Law Up to 48 Percent in February
TUESDAY, March 14, 2017 (HealthDay News) -- Support for the health law is increasing, with most Americans feeling that Medicaid should continue as it is today, according to a report published by Kaiser Health News.
Musculoskeletal Symptoms Predict Psoriatic Arthritis
MONDAY, March 13, 2017 (HealthDay News) -- For patients with psoriasis, nonspecific musculoskeletal symptoms, including joint pain, fatigue, and stiffness, predict the development of psoriatic arthritis (PsA), according to a study published in the March issue of Arthritis & Rheumatology.
Abstract
Full Text (subscription or payment may be required)
ACA's Medicaid Expansion May Pose Challenges to Timely Care
THURSDAY, March 9, 2017 (HealthDay News) -- People living in states that expanded Medicaid under the Affordable Care Act (ACA) are less likely to be uninsured or struggling with the strain of unpaid medical bills, but they also seem to have increased difficulty receiving timely care, according to research published in the March 9 issue of the New England Journal of Medicine.
Abstract/Full Text (subscription or payment may be required)
Republicans Introduce Affordable Care Act Replacement
TUESDAY, March 7, 2017 (HealthDay News) -- An initial Republican replacement for the Affordable Care Act was formally introduced in the House of Representatives on Monday.
CDC: Fewer Teens Using Tanning Beds
MONDAY, March 6, 2017 (HealthDay News) -- The number of U.S. teens who use indoor tanning has dropped by half in recent years, according to a study published online March 3 JAMA Dermatology.
Most Health Care Providers Can Offer Cost Estimate
MONDAY, March 6, 2017 (HealthDay News) -- Most provider organizations can offer a cost estimate, although few patients request one, according to a report published by Becker's Hospital CFO.
Cost-Effectiveness Compared for Metastatic Melanoma Treatments
MONDAY, March 6, 2017 (HealthDay News) -- For patients with BRAF wild-type metastatic melanoma, first-line pembrolizumab (PEM) every three weeks followed by second-line ipilumumab (IPI), or first-line nivolumab (NIVO) followed by IPI, are the most cost-effective strategies, according to a study published online Feb. 21 in the Journal of Clinical Oncology.
Judgement Bias in Medical Device Recall Decisions
FRIDAY, March 3, 2017 (HealthDay News) -- The characteristics of the signal in user feedback of adverse events associated with medical devices and the situated context of decision makers correlate with judgement bias in reacting to these adverse events, according to research published online Jan. 29 in Production and Operations Management.
Abstract
Full Text (subscription or payment may be required)
Tolerance Develops in NSAID-Induced Urticaria/Angioedema
FRIDAY, March 3, 2017 (HealthDay News) -- Patients with nonsteroidal anti-inflammatory drug (NSAID)-induced urticaria/angioedema (NIUA) may develop tolerance to NSAIDs over time, according to a study published online Feb. 22 in Allergy.
Abstract
Full Text (subscription or payment may be required)
Nemolizumab Found to Be Effective in Atopic Dermatitis
FRIDAY, March 3, 2017 (HealthDay News) -- An experimental drug, nemolizumab, may significantly reduce the itching and improve the appearance of moderate-to-severe atopic dermatitis, according to a study published in the March 2 issue of the New England Journal of Medicine.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Skin Diseases Responsible for Significant Economic Burden
FRIDAY, March 3, 2017 (HealthDay News) -- Skin diseases have a major impact on Americans and the U.S. economy, according to a report published online March 1 in the Journal of the American Academy of Dermatology.
ASPS Releases New Plastic Surgery Statistics
FRIDAY, March 3, 2017 (HealthDay News) -- The number of cosmetic procedures in the United States rose 3 percent last year from 2015, according to the American Society of Plastic Surgeons.
Sun Protection Behaviors Often Poor Among Melanoma Survivors
THURSDAY, March 2, 2017 (HealthDay News) -- A sizeable proportion of melanoma survivors still report elevated sun exposure, sunburns, and suboptimal ultraviolet radiation protection behaviors, according to research published online March 2 in Cancer Epidemiology, Biomarkers & Prevention.
Abstract/Full Text (subscription or payment may be required)
Overall, 8.8 Percent of U.S. Population Uninsured in 2016
THURSDAY, March 2, 2017 (HealthDay News) -- Overall, 8.8 percent of individuals of all ages were uninsured in the first nine months of 2016, which marked a nonsignificant reduction from 2015, according to a Feb. 14 report from the National Center for Health Statistics.
Variation in Cost of Actinic Keratosis Management
THURSDAY, March 2, 2017 (HealthDay News) -- There is considerable variation in the cost of actinic keratosis (AK) management, according to a study published online March 1 in JAMA Dermatology.
Abstract/Full Text
Editorial (subscription or payment may be required)
Pre-Op Phone Consult Doesn't Cut Anxiety Before Mohs Surgery
THURSDAY, March 2, 2017 (HealthDay News) -- Receiving a preoperative educational telephone call does not reduce anxiety or improve satisfaction for patients undergoing same-day office consultation and Mohs micrographic surgery (MMS), according to a study published in the March issue of the Journal of the American Academy of Dermatology.
Abstract
Full Text (subscription or payment may be required)
Indoor Tanning Cost U.S. Health Care $343 Million Annually
WEDNESDAY, March 1, 2017 (HealthDay News) -- Skin cancers linked to indoor tanning are estimated to have cost the U.S. health care system hundreds of millions of dollars in 2015, according to research published online Feb. 28 in the Journal of Cancer Policy.
Abstract/Full Text (subscription or payment may be required)
Salicylic Acid, Microdermabrasion Linked to Wound Healing
WEDNESDAY, March 1, 2017 (HealthDay News) -- Use of salicylic acid peeling and microdermabrasion are associated with dermal morphological changes consistent with the repair process, according to a study published online Feb. 22 in the Journal of Cosmetic Dermatology.
Abstract
Full Text (subscription or payment may be required)